ALNY

E446844

ALNY is the stock ticker symbol for Alnylam Pharmaceuticals, a biotechnology company specializing in RNA interference (RNAi) therapeutics.

All labels observed (2)

Label Occurrences
ALNY canonical 2
NASDAQ:ALNY 1

How this entity was disambiguated

Statements (48)

Predicate Object
instanceOf biotechnology company
public company
stock ticker symbol
collaboratesWith Novartis
Regeneron Pharmaceuticals
Sanofi (historical collaboration)
linked to: Sanofi
country United States
develops AMVUTTRA (vutrisiran)
GIVLAARI (givosiran)
ONPATTRO (patisiran)
linked to: Onpattro

OXLUMO (lumasiran)
employs scientists specializing in RNA interference
focusesOn RNAi-based drugs
genetic medicines
foundedBy David Bartel
David R. Corey
John Maraganore
Other co-founders associated with RNAi field
Paul Schimmel
Phil Zamore
Phillip A. Sharp
Thomas Tuschl
foundedIn 2002
hasAbbreviation Alnylam
hasCUSIP 02043Q107
hasISIN US02043Q1076
hasKeyPerson John Maraganore
Yvonne Greenstreet
hasModality gene silencing
hasPipeline RNAi therapeutics in clinical development
hasTherapeuticArea cardiometabolic diseases
central nervous system diseases
hepatic infectious diseases
rare diseases
headquartersLocation Cambridge, Massachusetts, United States
industry biotechnology
languageOfWork English
listedOn NASDAQ
regulatoryRegion United States Food and Drug Administration jurisdiction
represents Alnylam Pharmaceuticals, Inc.
specializesIn RNA interference therapeutics
RNAi therapeutics
targets mRNA for degradation via RNAi
technology RNA interference
tickerSymbol ALNY
tradedAs NASDAQ:ALNY
linked to: ALNY
usesDeliveryPlatform GalNAc conjugate delivery
lipid nanoparticle delivery

How these facts were elicited

Referenced by (3)

Full triples — surface form annotated when it differs from this entity's canonical label.

Alnylam Pharmaceuticals, Inc. tradedAs NASDAQ:ALNY
subject linked to: ALNY
linked to: ALNY
Alnylam Pharmaceuticals, Inc. tickerSymbol ALNY
subject linked to: ALNY